Expression of CX3CL1 (fractalkine) in mice with endothelial-target rickettsial infection of the spotted-fever group

Virchows Archiv

Volumn 446, Issue 1, 2005, Pages 21-27

  Valbuena, Gustavo ^a   Walker, David H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

CX3CL1; Fractalkine; Immunity; Rickettsia; Spotted fever mouse

Indexed keywords

CX3C CHEMOKINE; FRACTALKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INFECTION; KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RICKETTSIOSIS;

ANIMALS; BOUTONNEUSE FEVER; CHEMOKINES, CX3C; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; RICKETTSIA CONORII;

EID: 13144258770     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1120-3     Document Type: Article

References (36)

1. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644
2. Billings AN, Feng FJM, Olano JP, Walker DH (2001) Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon. Am J Trop Med Hyg 65:52-56
3. Dignat-George F, Teysseire N, Mutin M, Bardin N, Lesaule G, Raoult D, Sampol J (1997) Rickettsia conorii infection enhances vascular cell adhesion molecule-1- and intercellular adhesion molecule-1-dependent mononuclear cell adherence to endothelial cells. J Infect Dis 175:1142-1152
4. Efsen E, Grappone C, DeFranco RM, Milani S, Romanelli RG, Bonacchi A, Caligiuri A, Failli P, Annunziato F, Pagliai G, Pinzani M, Laffi G, Gentilini P, Marra F (2002) Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37:39-47
5. Feng HM, Popov VL, Walker DH (1994) Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infect Immun 62:1952-1960
6. Feng H, Popov VL, Yuoh G, Walker DH (1997) Role of T lymphocyte subsets in immunity to spotted fever group rickettsiae. J Immunol 158:5314-5320
7. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188:1413-1419
8. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107:1173-1181
9. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276:37993-38001
10. Guo J, Zhang M, Wang B, Yuan Z, Guo Z, Chen T, Yu Y, Qin Z, Cao X (2003) Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells. Int J Cancer 103:212-220
11. Haskell CA, Cleary MD, Charo IF (1999) Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274:10053-10058
12. Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, Faia K, Fituri O, Rottman JB, Charo IF (2001) Targeted deletion of CX(S)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 108:679-688
13. Heinzen RA, Hayes SF, Peacock MG, Hackstadt T (1993) Directional actin polymerization associated with spotted fever group rickettsia infection of Vero cells. Infect Immun 61:1926-1935
14. Heinzen RA, Grieshaber SS, Van Kirk LS, Devin CJ (1999) Dynamics of actin-based movement by Rickettsia rickettsii in vero cells. Infect Immun 67:4201-4207
15. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE (2001) Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 184:1437-1444
16. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186-1195
17. Kaplanski G, Teysseire N, Farnarier C, Kaplanski S, Lissitzky JC, Durand JM, Soubeyrand J, Dinarello CA, Bongrand P (1995) IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. J Clin Invest 96:2839-2844
18. Kaplowitz LG, Fischer JJ, Sparling PF (1981) Rocky Mountain spotted fever: a clinical dilemma. 89-108
19. Lesnik P, Haskell CA, Charo IF (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111:333-340
20. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T (2002) Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 168:6173-6180
21. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497
22. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, Bautch V, Patel DD, Feng L, Coffman TM (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067-6072
23. Sahni SK, Van Antwerp DJ, Eremeeva ME, Silverman DJ, Marder VJ, Sporn LA (1998) Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii. Infect Immun 66:1827-1833
24. Sporn LA, Lawrence SO, Silverman DJ, Marder VJ (1993) E-selectin-dependent neutrophil adhesion to Rickettsia rickettsii-infected endothelial cells. Blood 81:2406-2412
25. Sporn LA, Marder VJ (1996) Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation. Infect Immun 64:1609-1613
26. Sporn LA, Sahni SK, Lerner NB, Marder VJ, Silverman DJ, Turpin LC, Schwab AL (1997) Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation. Infect Immun 65:2786-2791
27. Valbuena G, Bradford W, Walker DH (2003) Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol 163:1357-1369
28. Van Kirk LS, Hayes SF, Heinzen RA (2000) Ultrastructure of Rickettsia rickettsii actin tails and localization of cytoskeletal proteins. Infect Immun 68:4706-4713
29. Walker DH (1982) Rickettsial diseases: an update. Monogr Pathol 188-204
30. Walker DH (1995) Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis 20:1111-1117
31. Walker DH, Cain BG (1980) The rickettsial plaque. Evidence for direct cytopathic effect of Rickettsia rickettsii. Lab Invest 43:388-396
32. Walker DH, TW Lane (1988) Rocky Mountain spotted fever: clinical signs, symptoms, and pathophysiology. In: Walker DH (ed) Biology of rickettsial diseases. CRC press, Boca Raton, pp 63-78
33. Walker DH, Popov VL, Wen J, Feng HM (1994) Rickettsia conorii infection of C3H/HeN mice. A model of endothelial-target rickettsiosis. Lab Invest 70:358-368
34. Walker DH, Popov VL, Feng HM (2000) Establishment of a novel endothelial target mouse model of a typhus group rickettsiosis: evidence for critical roles for gamma interferon and CD8 T lymphocytes. Lab Invest 80:1361-1372
35. Walker DH, Olano JP, Feng HM (2001) Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infect Immun 69:1841-1846
36. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T, Imai H, Yoshie O, Bloom ET, Domae N, Umehara H (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164:4055-4062